
Specialist - Clinical Trials
Among other responsibilities, the Specialist, Clinical Trials supports the operational activities for planning, initiation, conduct and close out of assigned Clinical Studies (domestic and global studies). Serves as team member for of assigned clinical studies. Prepares data / information for technical and study design discussions. Provides administrative support, ensuring invoices are paid, tracking metrics, issues for contract research organizations (CROs) and other contract service providers (CSPs) for assigned studies. Participates in study team meetings and tracks study issues. Under direction of the CTM, creates study timelines in accordance with corporate goals. Helps with recruitment efforts. Participates in internally run studies (without CROs) including updating monitoring plans, documenting on-site monitoring guidelines, forms, tools and may participate in onsite monitoring and co-monitoring visits, as necessary.
2+ years of clinical trials or operations experience
General understanding of Clinical Research industry and the relevant environments in which it operates
Particiaption in monitoring clinical trials or related experience preferred
Working knowledge of clinical operations specifically conducting clinical studies from start-up through close-out
Documentation
Project Management
Time Management
Analytical skills
Presentation skills
FDA/cGMP regulations
Process Improvement
Detail Oriented
Communication Skills
Problem-Solving
self-directed
According to JobzMall, the average salary range for a Specialist - Clinical Trials in 12780 El Camino Real, San Diego, CA 92130, USA is between $53,600 and $106,000. The salary range can vary depending on the experience of the individual and the type of organization they are working for.
Apply with Video Cover Letter Add a warm greeting to your application and stand out!
Neurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD). The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids.

Get interviewed today!
JobzMall is the world‘ s largest video talent marketplace.It‘s ultrafast, fun, and human.
Get Started